Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Botanix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Clinical Trials Tracker: 2022 and beyond
Health & Biotech
Botanix collab with UQ confirms antimicrobial potential of CBD
Health & Biotech
Superbugs will kill 22,000 Australians annually by 2040; but these stocks are trying to stop that
News
September Winners Column: Battery metals sentiment has come roaring back
Health & Biotech
Check up: dorsaVi leads ASX health gainers with 60pc rise
Health & Biotech
Weed Week: US cannabis companies wanna take it to the bank
Health & Biotech
This new antimicrobial resistance network could boost Recce, Botanix and Next Science
Health & Biotech
Zelira Therapeutics to launch cannabis-based toothpaste
Guides
Cannabis stocks guide: Here’s everything you need to know
Health & Biotech
Health Kick Podcast: Botanix is using synthetic cannabinoids to treat acne and other skin conditions
Health & Biotech
Experts: How to position for the next wave in cannabis
Health & Biotech
ASX investors super happy that FDA may approve first new contraceptive pill in 11 years
Health & Biotech
COVID-19 hasn’t hurt cannabis clinical trials … much
News
Weed Week: Local pot stocks join the party as ASX posts its best month in 32 years
News
10 at 10: These 10 ASX stocks are motoring on this morning
News
Short and Caught: The ASX stocks investors are shorting right now
News
